Three-dimensional solution structure and backbone dynamics of a variant of human interleukin-3.
暂无分享,去创建一个
C. Mcwherter | Y Feng | B K Klein | C A McWherter | Y. Feng | B. Klein | C. McWherter | Yiqing Feng | Barbara Kure Klein | Charles A. Mcwherter | C. A. Mcwherter
[1] M H Saier,et al. Backbone dynamics of the Bacillus subtilis glucose permease IIA domain determined from 15N NMR relaxation measurements. , 1992, Biochemistry.
[2] L. Kay,et al. Three-dimensional NOESY-HMQC spectroscopy of a 13C-labeled protein , 1990 .
[3] K. Wüthrich. NMR of proteins and nucleic acids , 1988 .
[4] R A Smith,et al. Human interleukin 4. The solution structure of a four-helix bundle protein. , 1992, Journal of molecular biology.
[5] D Eisenberg,et al. The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[6] J. Polazzi,et al. Saturation Mutagenesis of Human Interleukin-3 (*) , 1995, The Journal of Biological Chemistry.
[7] K. Arai,et al. Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[8] V. Broudy,et al. Structure-function relationships of interleukin-3. An analysis based on the function and binding characteristics of a series of interspecies chimera of gibbon and murine interleukin-3. , 1992, The Journal of clinical investigation.
[9] L. Kanz,et al. In vivo biology and therapeutic potential of hematopoietic growth factors and circulating progenitor cells. , 1992, Seminars in Oncology.
[10] A. Gronenborn,et al. Analysis of the backbone dynamics of interleukin-1.beta. using two-dimensional inverse detected heteronuclear nitrogen-15-proton NMR spectroscopy , 1990 .
[11] C. Bugg,et al. Three-dimensional structure of recombinant human granulocyte-macrophage colony-stimulating factor. , 1992, Journal of molecular biology.
[12] K. Wüthrich,et al. Contributions from hydration of carboxylate groups to the spectrum of water-polypeptide proton-proton Overhauser effects in aqueous solution , 1993, Journal of biomolecular NMR.
[13] J. Freeman,et al. Secondary structure of human interleukin-3. , 1991, The International journal of biochemistry.
[14] R. Kastelein,et al. The amino‐terminal helix of GM‐CSF and IL‐5 governs high affinity binding to their receptors. , 1991, The EMBO journal.
[15] S E Ealick,et al. Three-dimensional structure of recombinant human interferon-gamma. , 1991, Science.
[16] J. Bazan. Unraveling the structure of IL-2. , 1992, Science.
[17] Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release. , 1988, The Journal of clinical investigation.
[18] K. Arai,et al. Definition of a GC-rich motif as regulatory sequence of the human IL-3 gene: coordinate regulation of the IL-3 gene by CLE2/GC box of the GM-CSF gene in T cell activation. , 1991, International immunology.
[19] K. Arai,et al. Function of the common beta subunit of the GM-CSF/IL-3/IL-5 receptors. , 1994, Advances in experimental medicine and biology.
[20] Y. Mitsui,et al. Three‐dimensional crystal structure of recombinant murine interferon‐beta. , 1992, The EMBO journal.
[21] J. Tavernier,et al. Three residues in the common beta chain of the human GM‐CSF, IL‐3 and IL‐5 receptors are essential for GM‐CSF and IL‐5 but not IL‐3 high affinity binding and interact with Glu21 of GM‐CSF. , 1994, The EMBO journal.
[22] A. Ganser,et al. Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure. , 1990, Blood.
[23] A. Ganser,et al. Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure. , 1990, Blood.
[24] C. Baum,et al. Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[25] Axel T. Brunger,et al. X-PLOR Version 3.1: A System for X-ray Crystallography and NMR , 1992 .
[26] A. Palmer,et al. Backbone dynamics of calcium-loaded calbindin D9k studied by two-dimensional proton-detected 15N NMR spectroscopy. , 1992, Biochemistry.
[27] J. Tavernier,et al. A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific α chain and a β chain shared with the receptor for GM-CSF , 1991, Cell.
[28] A M Gronenborn,et al. Determination of three-dimensional structures of proteins in solution by nuclear magnetic resonance spectroscopy. , 1987, Protein engineering.
[29] A. Tominaga,et al. Reconstitution of the functional receptors for murine and human interleukin 5 , 1993, The Journal of experimental medicine.
[30] L. Kay,et al. Simultaneous Acquisition of 15N- and 13C-Edited NOE Spectra of Proteins Dissolved in H2O , 1994 .
[31] S. Fesik,et al. Heteronuclear three-dimensional NMR spectroscopy of the inflammatory protein C5a. , 1989, Biochemistry.
[32] M. Vadas,et al. Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[33] C. Mcwherter,et al. 1H, 13C, and 15N NMR resonance assignments, secondary structure, and backbone topology of a variant of human interleukin-3. , 1995, Biochemistry.
[34] A. Gronenborn,et al. Determination of three‐dimensional structures of proteins from interproton distance data by hybrid distance geometry‐dynamical simulated annealing calculations , 1988, FEBS letters.
[35] S. Leach,et al. Cytokine conformations: Predictive studies , 1991, Journal of molecular recognition : JMR.
[36] A. Gustchina,et al. Crystal structure of human recombinant interleukin‐4 at 2.25 Å resolution , 1992, FEBS letters.
[37] N. Sato,et al. JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region , 1994, Molecular and cellular biology.
[38] K. Kaushansky,et al. Mapping of human granulocyte-macrophage-colony-stimulating-factor domains interacting with the human granulocyte-macrophage-colony-stimulating-factor-receptor alpha-subunit. , 1994, European journal of biochemistry.
[39] Mike Carson,et al. RIBBONS 2.0 , 1991 .
[40] M. Lambert,et al. A novel dimer configuration revealed by the crystal structure at 2.4 Å resolution of human interleukin-5 , 1993, Nature.
[41] Ad Bax,et al. Three-dimensional heteronuclear NMR of nitrogen-15 labeled proteins , 1989 .
[42] J. Pandit,et al. Three-dimensional structure of dimeric human recombinant macrophage colony-stimulating factor. , 1992, Science.
[43] M. F. Shannon,et al. Interaction of GM‐CSF and IL‐3 with the common β‐chain of their receptors , 1995, Journal of leukocyte biology.
[44] Yu-Chung Yang,et al. Human IL-3 (multi-CSF): Identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3 , 1986, Cell.
[45] D. Eisenberg,et al. Crystal structure of canine and bovine granulocyte-colony stimulating factor (G-CSF). , 1993, Journal of molecular biology.
[46] A. Brunger. Crystallographic refinement by simulated annealing , 1988 .
[47] T. Pawson,et al. Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. , 1994, Biochemistry.
[48] L. Kay,et al. New methods for the measurement of NHCαH coupling constants in 15N-labeled proteins , 1990 .
[49] B. Violand,et al. Three-dimensional structure of a genetically engineered variant of porcine growth hormone. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[50] H. Gerhartz,et al. Interleukin-3 enhances the endogenous leukotriene production. , 1993, Blood.
[51] P. Kraulis,et al. Determination of the three-dimensional solution structure of the C-terminal domain of cellobiohydrolase I from Trichoderma reesei. A study using nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing. , 1989, Biochemistry.
[52] L. Kay,et al. Backbone dynamics of proteins as studied by 15N inverse detected heteronuclear NMR spectroscopy: application to staphylococcal nuclease. , 1989, Biochemistry.
[53] K. Diederichs,et al. Novel fold and putative receptor binding site of granulocyte-macrophage colony-stimulating factor. , 1991, Science.
[54] A. Brünger. Crystallographic refinement by simulated annealing. Application to a 2.8 A resolution structure of aspartate aminotransferase. , 1988, Journal of molecular biology.
[55] M. F. Shannon,et al. A human interleukin 3 analog with increased biological and binding activities. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[56] J. Vera,et al. The alpha subunit of the human granulocyte-macrophage colony-stimulating factor receptor signals for glucose transport via a phosphorylation-independent pathway. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[57] J. Zou,et al. Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.
[58] E. Vellenga,et al. Effects of interleukin-3 after chemotherapy for advanced ovarian cancer. , 1992, Blood.
[59] M. Ultsch,et al. The crystal structure of affinity-matured human growth hormone at 2 A resolution. , 1994, Journal of molecular biology.
[60] K. Constantine,et al. Characterization of the backbone dynamics of an anti‐digoxin antibody VL domain by inverse detected 1H–15N NMR: Comparisons with X‐ray data for the Fab , 1993, Proteins.
[61] W. Kabsch,et al. Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.
[62] P. Kraulis. A program to produce both detailed and schematic plots of protein structures , 1991 .
[63] Paul A. Keifer,et al. Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity , 1992 .
[64] D. Metcalf. The hemopoietic colony stimulating factors , 1984 .
[65] I. Campbell,et al. Secondary structure of human interleukin 2 from 3D heteronuclear NMR experiments. , 1992, Biochemistry.
[66] N. Nicola,et al. The Hemopoietic Colony-stimulating Factors: From Biology to Clinical Applications , 1995 .
[67] D. M. Schneider,et al. Fast internal main-chain dynamics of human ubiquitin. , 1992, Biochemistry.
[68] M. Ultsch,et al. The X-ray structure of a growth hormoneprolactin receptor complex , 1994, Nature.
[69] T. Holak,et al. Structure and dynamics of the human granulocyte colony-stimulating factor determined by NMR spectroscopy. Loop mobility in a four-helix-bundle protein. , 1994, Biochemistry.
[70] S. Leach,et al. Conformational homologies among cytokines: Interleukins and colony stimulating factors , 1988, Journal of molecular recognition : JMR.
[71] T. L. Nagabhushan,et al. Crystal structure of interleukin 10 reveals an interferon gamma-like fold. , 1995, Biochemistry.
[72] A. Szabó,et al. Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Theory and range of validity , 1982 .
[73] R. Kastelein,et al. Identification of critical amino acid residues in human and mouse granulocyte-macrophage colony-stimulating factor and their involvement in species specificity. , 1991, The Journal of biological chemistry.
[74] K. Arai,et al. Expression cloning of the human IL-3 receptor cDNA reveals a shared β subunit for the human IL-3 and GM-CSF receptors , 1991, Cell.
[75] B. Fagg,et al. Structure‐activity relationship study of human interleukin‐3: role of the C‐terminal region for biological activity. , 1991, The EMBO journal.
[76] A. Gronenborn,et al. Analysis of the backbone dynamics of interleukin-1 beta using two-dimensional inverse detected heteronuclear 15N-1H NMR spectroscopy. , 1990, Biochemistry.
[77] M. Peitsch,et al. Identification of Key Charged Residues of Human Interleukin-5 in Receptor Binding and Cellular Activation (*) , 1995, The Journal of Biological Chemistry.
[78] L. Kay,et al. Studies on the solution conformation of human thioredoxin using heteronuclear 15N-1H nuclear magnetic resonance spectroscopy. , 1990, Biochemistry.
[79] M. Ultsch,et al. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.
[80] A. Kelso,et al. GM-CSF expression is preferential to multi-CSF (IL-3) expression in murine T lymphocyte clones. , 1989, Growth factors.
[81] D. Gearing,et al. Expression cloning of a receptor for human granulocyte‐macrophage colony‐stimulating factor. , 1989, The EMBO journal.
[82] D. S. Garrett,et al. Three-dimensional solution structure of human interleukin-4 by multidimensional heteronuclear magnetic resonance spectroscopy. , 1993, Science.
[83] M Nilges,et al. Calculation of protein structures with ambiguous distance restraints. Automated assignment of ambiguous NOE crosspeaks and disulphide connectivities. , 1995, Journal of molecular biology.
[84] L. Kay,et al. Enhanced-Sensitivity Triple-Resonance Spectroscopy with Minimal H2O Saturation , 1994 .
[85] B. Fagg,et al. Mapping the epitopes of neutralizing anti-human IL-3 monoclonal antibodies. Implications for structure-activity relationship. , 1991, Journal of immunology.
[86] M. F. Shannon,et al. Residue 21 of human granulocyte‐macrophage colony‐stimulating factor is critical for biological activity and for high but not low affinity binding. , 1992, The EMBO journal.
[87] Colin R. Janssen,et al. Receptor and antibody interactions of human interleukin-3 characterized by mutational analysis. , 1991, The Journal of biological chemistry.
[88] T. Holak,et al. Secondary structure of human granulocyte colony‐stimulating factor derived from NMR spectroscopy , 1992, FEBS letters.
[89] A. Miyajima,et al. Functional reconstitution of the human interleukin-3 receptor. , 1992, Blood.
[90] A Wlodawer,et al. Structural comparisons among the short-chain helical cytokines. , 1994, Structure.
[91] I. Campbell,et al. Secondary structure and backbone dynamics of human granulocyte colony-stimulating factor in solution. , 1994, Biochemistry.
[92] A. Ganser,et al. Clinical results with recombinant human interleukin-3. , 1993, Cancer investigation.
[93] H. Erdjument-Bromage,et al. Interleukin‐3 signals through multiple isoforms of Stat5. , 1995, The EMBO journal.
[94] P. Wright,et al. Intramolecular motions of a zinc finger DNA-binding domain from Xfin characterized by proton-detected natural abundance carbon-13 heteronuclear NMR spectroscopy , 1991 .
[95] M. Karplus,et al. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .
[96] D. Stuart,et al. The crystal structure and biological function of leukemia inhibitory factor: Implications for receptor binding , 1994, Cell.
[97] B. Lee,et al. The interpretation of protein structures: estimation of static accessibility. , 1971, Journal of molecular biology.
[98] J. Schrader,et al. A T cell-derived factor stimulating multipotential hemopoietic stem cells: molecular weight and distinction from T cell growth factor and T cell-derived granulocyte-macrophage colony-stimulating factor. , 1982, Journal of immunology.
[99] J. Bazan,et al. Haemopoietic receptors and helical cytokines. , 1990, Immunology today.
[100] C. Dobson,et al. Secondary structure and topology of human interleukin 4 in solution. , 1991, Biochemistry.